Volume 10 - Issue 1 - January, 2002
Letter from the Editor
06/19/2008
Bernadette Longo, PhD
For patients requiring percutaneous vascular access procedures, the event is seldom limited to a single occurrence. Frequently, after the procedural catheter is removed and the arteriotomy closed, the event is considered over and done that...
For patients requiring percutaneous vascular access procedures, the event is seldom limited to a single occurrence. Frequently, after the procedural catheter is removed and the arteriotomy closed, the event is considered over and done that...
For patients requiring...
06/19/2008
Cath Lab Digest
06/19/2008
Susan Heilman; John Rader; Jennifer Williams
06/19/2008
Cath Lab Digest
Letter from the Editor
06/19/2008
Habib Samady, MD; Michael C. McDaniel, MD
By significantly reducing restenosis rates, drug-eluting stents (DES) have allowed interventional cardiologists to approach longer and more complex lesions, as well as multi-vessel disease patients. This dramatic reduction in restenosis has...
By significantly reducing restenosis rates, drug-eluting stents (DES) have allowed interventional cardiologists to approach longer and more complex lesions, as well as multi-vessel disease patients. This dramatic reduction in restenosis has...
By significantly reducing...
06/19/2008
Cath Lab Digest
06/19/2008
Cath Lab Digest
Industry Insider
06/19/2008
Terumo Announces the Release of its Pinnacle R/O II
Introducer Sheath with Radiopaque Marker
Terumo Medical Corporation has just released its newest vascular access product: the Pinnacle R/O II Introducer Sheath with Radiopaque Marker.
The...
Terumo Announces the Release of its Pinnacle R/O II
Introducer Sheath with Radiopaque Marker
Terumo Medical Corporation has just released its newest vascular access product: the Pinnacle R/O II Introducer Sheath with Radiopaque Marker.
The...
Terumo Announces the Release of...
06/19/2008
Cath Lab Digest
Letter from the Editor
06/19/2008
A sampling of recent conclusions from researchers around the world.
Chondroitin sulfate and gelatin (CSG) coating appears to be a promising medium for localized drug delivery. Paclitaxel polymer-coated stents reduce neointima formation but...
A sampling of recent conclusions from researchers around the world.
Chondroitin sulfate and gelatin (CSG) coating appears to be a promising medium for localized drug delivery. Paclitaxel polymer-coated stents reduce neointima formation but...
A sampling of recent conclusions...
06/19/2008
Cath Lab Digest
Feature
06/19/2008
V.S. Srinivas, MBBS; Sridhar Sampath Kumar, MD; Abdissa Negassa, PhD; E. Scott Monrad, MD
06/19/2008
Cath Lab Digest
Letter from the Editor
06/19/2008
Kathy Acquaviva, RCIS, RT(R)
06/19/2008
Cath Lab Digest
Feature
06/19/2008
Cath Lab Digest
Letter from the Editor
06/19/2008
The buzz in the trenches is coated stents, no doubt. This month, we offer a quick summary, and list conclusions from some of the published research over the past few months.
The more immediate future, however, holds another question: is...
The buzz in the trenches is coated stents, no doubt. This month, we offer a quick summary, and list conclusions from some of the published research over the past few months.
The more immediate future, however, holds another question: is...
The buzz in the trenches is...
06/19/2008
Cath Lab Digest
